BMS-214662
≥99%
- Product Code: 57656
CAS:
195987-41-8
Molecular Weight: | 489.61 g./mol | Molecular Formula: | C₂₅H₂₃N₅O₂S₂ |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | 2-8℃ |
Product Description:
BMS-214662 is primarily investigated for its potential in cancer therapy, particularly as a farnesyltransferase inhibitor. It targets and inhibits the farnesyltransferase enzyme, which plays a crucial role in the activation of certain proteins involved in cancer cell growth and survival. By blocking this enzyme, it disrupts the signaling pathways that promote tumor progression, making it a promising candidate for treating various cancers, including pancreatic and breast cancer. Research is ongoing to explore its efficacy in combination with other therapies to enhance its anticancer effects.
Sizes / Availability / Pricing:
Size (g) | Availability | Price | Quantity |
---|---|---|---|
0.001 | 10-20 days | ฿15,390.00 |
+
-
|
0.005 | 10-20 days | ฿35,910.00 |
+
-
|
BMS-214662
BMS-214662 is primarily investigated for its potential in cancer therapy, particularly as a farnesyltransferase inhibitor. It targets and inhibits the farnesyltransferase enzyme, which plays a crucial role in the activation of certain proteins involved in cancer cell growth and survival. By blocking this enzyme, it disrupts the signaling pathways that promote tumor progression, making it a promising candidate for treating various cancers, including pancreatic and breast cancer. Research is ongoing to explore its efficacy in combination with other therapies to enhance its anticancer effects.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :